Source: The New England Journal of Medicine. Unidade: FMRP
Subjects: PRESSÃO SANGUÍNEA, INFARTO DO MIOCÁRDIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PITT, B. et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. The New England Journal of Medicine, v. 348, n. 14, p. 1309-1321, 2003Tradução . . Disponível em: https://doi.org/10.1016/s1062-1458(03)00290-3. Acesso em: 05 maio 2026.APA
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., et al. (2003). Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. The New England Journal of Medicine, 348( 14), 1309-1321. doi:10.1016/s1062-1458(03)00290-3NLM
Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M, Pazin-Filho A. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction [Internet]. The New England Journal of Medicine. 2003 ; 348( 14): 1309-1321.[citado 2026 maio 05 ] Available from: https://doi.org/10.1016/s1062-1458(03)00290-3Vancouver
Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M, Pazin-Filho A. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction [Internet]. The New England Journal of Medicine. 2003 ; 348( 14): 1309-1321.[citado 2026 maio 05 ] Available from: https://doi.org/10.1016/s1062-1458(03)00290-3
